Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2013
11/20/2013EP1489082B1 Intermediate compounds
11/20/2013CN103396420A Reagent, and its application in detection of divalent zinc ions
11/20/2013CN102443388B Reagent and application thereof in detection of cupric ion
11/20/2013CN102378574B Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
11/20/2013CN102056899B Polycyclic compound and organic electroluminescent device using the same
11/20/2013CN102015680B New substituted indolin-2-one derivatives and use thereof as p38 mitogen-activated kinase inhibitors
11/19/2013US8586764 Organic dyes and preparation method thereof and dye-sensitized solar cells
11/19/2013US8586598 CDK inhibitor salts
11/19/2013US8586579 Anellated pyridine compounds
11/19/2013CA2707418C Inhibitors of human immunodeficiency virus replication
11/19/2013CA2446620C Antiviral nucleosides
11/14/2013WO2013168760A1 Aromatic ring compound
11/14/2013WO2013168759A1 Aromatic ring compound
11/14/2013WO2013167514A1 New 2,3-dihydro-furo[2,3-c]pyridines, their use as modulators of the g-protein-coupled receptor gpr119 and pharmaceutical compositions comprising them
11/14/2013US20130303565 Use of a new histamine h4 agonist for the treatment of acute leukemia
11/14/2013US20130303550 Chromene derivatives and their analoga as wnt pathway antagonists
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/14/2013US20130303375 Plant growth regulating compounds
11/14/2013US20130303370 Herbicidal compounds
11/14/2013US20130302303 Protein kinase inhibitors
11/14/2013US20130302282 Inhibitors of Hepatitis C Virus
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2661431A2 Heterocyclic compounds for the inhibition of pask
11/13/2013EP2661265A1 Quinolines and aza-quinolines as crth2 receptor modulators
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN103387583A Diaryl [a, g] quinolizidine compound, preparation method thereof, pharmaceutical composition, and uses thereof
11/13/2013CN103387580A Stemona root alkaloid monomer components and applications thereof
11/13/2013CN102321091B Method for preparing coumarin laser dye
11/13/2013CN101671336B Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
11/13/2013CN101506161B Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
11/12/2013US8580972 Processes for the preparation of 5-chloro-2-methyl-2,3,3A,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
11/12/2013US8580812 Heteroaryl amide analogues as P2X7 antagonists
11/12/2013US8580793 Use of kinase inhibitor for the treatment of thymoma
11/12/2013US8580161 Fluidic devices comprising photocontrollable units
11/12/2013CA2621836C Isoquinolines as igf-1r inhibitors
11/07/2013WO2013165189A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
11/07/2013WO2013164102A1 Process for preparation of ixabepilone and intermediates useful in said process.
11/07/2013US20130296569 Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
11/07/2013US20130296554 C-17 bicyclic amines of triterpenoids with hiv maturation inhibitory activity
11/07/2013US20130296377 Complement pathway modulators and uses thereof
11/07/2013US20130296354 2,3-DIHYDROFURO[2,3-c]PYRIDINES, THEIR USE AS MODULATORS OF THE G-PROTEIN-COUPLED RECEPTOR GPR119 AND PHARMACEUTICAL COMPOSITIONS THEREOF
11/07/2013US20130296344 Chromene derivatives and their analoga as wnt pathway antagonists
11/07/2013US20130296300 Quinolines and aza-quinolines as crth2 receptor modulators
11/07/2013US20130295040 Polymer
11/06/2013CN103384668A Novel compounds and compositions for the inhibition of NAMPT
11/06/2013CN103382207A Methylbenzofuran quinoline derivative, preparation method thereof, and application of derivative as antitumor drug
11/06/2013CN103382206A Quinoline or quinazoline derivative, its preparation method and application in medicines
11/06/2013CN103382201A Heteroaryl derivatives as cftr modulators
11/06/2013CN103382178A Condensed-cyclic compound and organic light-emitting diode comprising the same
11/06/2013CN102634225B Method for resolving and synthetizing 5(6) substitutional rhodamine isomer
11/05/2013US8575337 Oxazolidinone derivative having fused ring
11/05/2013US8575188 Camptothecin derivatives
11/05/2013US8575149 5HT2C receptor modulators
11/05/2013CA2656064C Polymorphic forms and process
11/05/2013CA2590157C Solid forms of a chemokine receptor antagonist and methods of use thereof
10/2013
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013160728A1 Dual targeting compounds for the treatment of alzheimer's disease
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/31/2013US20130289075 Iap binding compounds
10/31/2013US20130289063 Ccr1 antagonists and methods of use therefor
10/31/2013US20130289047 Heteroarylthio derivatives and analogues
10/31/2013US20130289030 Novel phenazine derivatives and their uses
10/31/2013US20130289016 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
10/31/2013US20130288371 Use of parthenolide derivatives as antileukemic and cytotoxic agents
10/30/2013EP2655378A1 Compounds and their use as bace inhibitors
10/30/2013EP2655377A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2655344A1 Novel phenazine derivatives and their use
10/30/2013CN103380191A Compounds for electronic devices
10/30/2013CN103380133A Compounds and their use as BACE inhibitors
10/30/2013CN103374015A Camptothecin derivative and preparation method thereof as well as application of camptothecin derivative in preparation of medicine for treating tumours
10/30/2013CN103374014A Salt of chelidonine derivative
10/30/2013CN103374013A Salt of dihydrosanguinarine derivative
10/30/2013CN103374012A Salt of sanguinarine derivative
10/30/2013CN103374011A Salt of dihydro nitidine derivative
10/30/2013CN103374010A Salt of methoxy dihydronitidine derivate
10/30/2013CN103374009A Salt of nitidine derivative
10/30/2013CN103374008A Salt of chelerythrine derivative
10/30/2013CN103374007A Salt of dihydrochelerythrine derivative
10/30/2013CN103374006A Natural medicament for inhibiting hepatitis virus
10/30/2013CN103374005A New method for synthesis of substituted furo-piperidine derivatives
10/30/2013CN102268005B Indole diketopiperazine alkaloid compound derived from tryptophan and proline and preparation method and application thereof
10/30/2013CN102260271B Cytochalasin compound as well as preparation method thereof and purpose
10/30/2013CN102250105B Camptothecin derivatives, synthesis method thereof and use thereof
10/30/2013CN102161608B Method for improving stereoselectivity of intramolecular photocyclization reaction
10/29/2013US8569500 Terrylene and quaterrylene derivatives
10/29/2013US8569347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/24/2013WO2013159064A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013156431A1 Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
10/24/2013US20130281697 Polymorphic forms alpha, beta and gamma of rifaximin
10/24/2013US20130281689 Compositions and methods of making a photoactive agent
10/24/2013US20130281482 Nicotinic acetylcholine receptor agonists
10/24/2013US20130281448 Small molecule compounds for targeting inflammatory conditions
10/24/2013US20130281443 Inhibitors of focal adhesion kinase
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 298